Broad Institute

OCTOBER 4, 2023

Marvin Caruthers for developing technology that efficiently synthesizes DNA The inaugural Richard N. Caruthers of the University of Colorado Boulder in a ceremony and symposium at the Broad Institute on September 21, 2023. Merkin Prize in Biomedical Technology was awarded to Marvin H.

DNA 52

DNA RNA Science Protein Expression 52

Drug Discovery World

AUGUST 29, 2024

HT surface plasmon resonance In the field of antibody research, Eli Lilly and AbCellera have credited Carterra’s LSA biosensor which uses High-Throughput Surface Plasmon Resonance (HT-SPR) technology for enabling a clinical candidate in less than 90 days. “SPR

Small Molecule 147

Small Molecule Drugs Protein Expression Assay Development 147

Drug Discovery World

SEPTEMBER 25, 2024

Additionally, the dynamic nature of tumour biology means that these targets can change over time, or under treatment pressure, necessitating continuous research and adaptation.” Stefan Ries is Chief Scientific Officer at DISCO Pharmaceuticals, a German company specialising in finding targets for targeted therapies such as ADCs.

Therapies 162

Therapies Pharma Companies FDA Approval FDA 162

Drug Target Review

SEPTEMBER 4, 2023

Infectious agents’ resistance was described at the European Union Research Parliament “as a widespread, multifaceted phenomenon that affects both living things and the environment, as well as their capacity to survive in the presence of drugs intended to either kill or inactivate them.”

Drugs 111

Drugs RNA DNA Disease 111

Drug Discovery World

APRIL 17, 2024

DDW’s Diana Spencer speaks to Josh Mandel-Brehm , CEO of Massachusetts-based biotech CAMP4, to understand the role regulatory RNAs play in gene expression and how the founders overcame the challenge of launching a business based on brand new science. DS: How easy was it to transfer theoretical research into a viable business?

Science 147

Science RNA Disease Protein Expression 147

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’.

Engineering 130

Engineering Therapies Protein Production Science 130

Drug Discovery World

NOVEMBER 30, 2023

DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023. This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7

Protein Expression 147

Protein Expression Engineering DNA Therapies 147